Remove Competition Remove Government Remove Pharma Remove Prescription
article thumbnail

Pharma is “big business” that uses excuses to keep prices high

World of DTC Marketing

Seventy-nine percent of Americans think the price of prescription drugs is “unreasonable,” according to a 2019 Kaiser Family Foundation poll , and about 9 in 10 say they support the idea of the government negotiating prices. Big Pharma’s chokehold around the U.S. Via Axios “The 10 highest-selling drugs in the U.S.

Pharma 241
article thumbnail

Pharma says VPAS clawback jeopardises UK sector

pharmaphorum

A pharma industry organisation has warned that record levels of revenue clawback from the UK government is threatening “footprint, R&D and manufacturing investments” in the country. billion (around $4 billion) in revenue to the government – 26.5% billion (around $4 billion) in revenue to the government – 26.5%

Pharma 70
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The debate on DTC marketing is going to heat up again

World of DTC Marketing

SUMMARY: DTC marketing is not the reason why prescription drugs cost so much. Here are some myths around DTC marketing: 1ne: DTC ads result in patients asking for prescriptions they don’t need. 2wo: DTC marketing is one of the reasons prescription drugs cost so much. DTC ads raise awareness around health conditions.

Marketing 285
article thumbnail

Entry-Level Pharma Sales: It's More Than Just a Job Search (Here's Why)

Contrarian Sales Techniques

In this blog post, I’d like to go deeper into that world, and not just finding an entry-level position in a Pharma company. prescription drugs, medical devices), or specific companies. Regulatory compliance: Familiarize yourself with relevant regulations that govern pharmaceutical sales practices.

Sales 52
article thumbnail

Two Key Questions About Payer Strategies in 2023

PM360

What other policy issues or potential changes by the government should companies be aware of? However, we expect drugs without strong therapeutic alternatives to have an advantage in negotiations, while drugs in highly competitive classes will be negotiating from a weaker position. The 340B battle will rage on.

article thumbnail

Pharma sector reels as UK Government doubles VPAS payback rate on NHS drugs

Pharmaceutical Technology

The UK government’s decision to set an unprecedented payback rate of 26.5% on National Health Service (NHS) sales of branded medicines in 2023, almost double that of the previous year, has sent shock waves through the pharma industry. Calculations behind the jump in payback rate The government-calculated 2023 clawback level of 26.5%

article thumbnail

Shareholders versus patients: Who is more important?

World of DTC Marketing

SKIMMERS SUMMARY: There is one and only one social responsibility of business–to use its resources and engage in activities designed to increase its profits so long as it stays within the rules of the game, which is to say, engages in open and free competition without deception or fraud. Milton Friedman.

Patients 156